The biosensor detects biomolecular bindings and neutralizing antibodies in real-time, suggesting applications for infectious diseases.
We present a four-dimensional (4D) Surface Plasmon Resonance (SPR) Imaging biosensor for real-time, array based high-through biomolecular bindings detection. The sensor measures the sensitive phase change induced spectral colour variation at plasmonic resonance with imaging device. It captures two-dimensional biomolecular bindings signal in the time-domain with spectral colour space information (4D imaging data), while no complex phase extraction is required. In the experiment, measurements for refractive index (RI) samples in 1.3330-1.3455 RIU were performed and the sensor RI resolution was found to be 7.2 x 10 -6 RIU. The sensor was further demonstrated for antibodies molecular bindings detection in a 5 x 5 array format and 25 biomolecular binding interactions were monitored in real-time. In on-going works, we apply the imaging biosensor for Monkeypox virus neutralizing antibodies detection, which can contribute to Monkeypox virus vaccination development.
No takes yet. Share an insight, caveat, or question.
Chi Lok Wong (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: